| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ZNF419 ZNF93 ZNF131 KLF12 ZNF676 ZNF320 ZBTB17 ZNF560 KLF10 ZNF473 ZNF423 ZNF587 ZNF846 ZNF66 ZNF621 ZNF772 ZNF723 REST ZNF90 ZNF763 ZNF626 ZNF417 ZNF840P PRDM2 | 2.91e-11 | 1459 | 68 | 24 | GO:0000977 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | ZNF419 ZNF93 ZNF131 KLF12 ZNF676 ZNF320 ZBTB17 KLF10 ZNF473 ZNF423 ZNF587 ZNF66 ZNF621 ZNF772 ZNF723 REST ZNF90 ZNF763 ZNF626 ZNF417 ZNF840P TIPARP | 9.57e-11 | 1271 | 68 | 22 | GO:0000987 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | ZNF419 ZNF93 ZNF131 KLF12 ZNF676 ZNF320 ZBTB17 ZNF560 KLF10 ZNF473 ZNF423 ZNF587 ZNF846 ZNF66 ZNF621 ZNF772 ZNF723 REST ZNF90 ZNF626 ZNF417 ZNF840P PRDM2 | 1.05e-10 | 1412 | 68 | 23 | GO:0000981 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | ZNF419 ZNF93 ZNF131 KLF12 ZNF676 ZNF320 ZBTB17 KLF10 ZNF473 ZNF423 ZNF587 ZNF66 ZNF621 ZNF772 ZNF723 REST ZNF90 ZNF763 ZNF626 ZNF417 ZNF840P | 4.57e-10 | 1244 | 68 | 21 | GO:0000978 |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity, RNA polymerase II-specific | 7.68e-04 | 320 | 68 | 6 | GO:0001227 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity | 8.46e-04 | 326 | 68 | 6 | GO:0001217 | |
| GeneOntologyMolecularFunction | core promoter sequence-specific DNA binding | 8.73e-04 | 55 | 68 | 3 | GO:0001046 | |
| Domain | - | ZNF419 ZNF93 ZNF131 KLF12 ZNF676 ZNF320 ZBTB17 ZNF560 KLF10 ZNF473 ZNF423 ZNF587 ZNF846 ZNF621 ZNF772 REST ZNF90 ZNF763 ZNF626 ZNF417 ZFPM2 PRDM2 | 4.30e-16 | 679 | 65 | 22 | 3.30.160.60 |
| Domain | zf-C2H2 | ZNF419 ZNF93 ZNF131 KLF12 ZNF676 ZNF320 ZBTB17 ZNF560 KLF10 ZNF473 ZNF423 ZNF587 ZNF846 ZNF621 ZNF772 REST ZNF90 ZNF763 ZNF626 ZNF417 ZFPM2 PRDM2 | 6.57e-16 | 693 | 65 | 22 | PF00096 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF419 ZNF93 ZNF131 KLF12 ZNF676 ZNF320 ZBTB17 ZNF560 KLF10 ZNF473 ZNF423 ZNF587 ZNF846 ZNF621 ZNF772 REST ZNF90 ZNF763 ZNF626 ZNF417 ZFPM2 PRDM2 | 6.77e-16 | 694 | 65 | 22 | IPR013087 |
| Domain | ZINC_FINGER_C2H2_2 | ZNF419 ZNF93 ZNF131 KLF12 ZNF676 ZNF320 ZBTB17 ZNF560 KLF10 ZNF473 ZNF423 ZNF587 ZNF846 ZNF621 ZNF772 REST ZNF90 ZNF763 ZNF626 ZNF417 ZFPM2 PRDM2 | 6.61e-15 | 775 | 65 | 22 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF419 ZNF93 ZNF131 KLF12 ZNF676 ZNF320 ZBTB17 ZNF560 KLF10 ZNF473 ZNF423 ZNF587 ZNF846 ZNF621 ZNF772 REST ZNF90 ZNF763 ZNF626 ZNF417 ZFPM2 PRDM2 | 6.97e-15 | 777 | 65 | 22 | PS00028 |
| Domain | Znf_C2H2-like | ZNF419 ZNF93 ZNF131 KLF12 ZNF676 ZNF320 ZBTB17 ZNF560 KLF10 ZNF473 ZNF423 ZNF587 ZNF846 ZNF621 ZNF772 REST ZNF90 ZNF763 ZNF626 ZNF417 ZFPM2 PRDM2 | 1.14e-14 | 796 | 65 | 22 | IPR015880 |
| Domain | Znf_C2H2 | ZNF419 ZNF93 ZNF131 KLF12 ZNF676 ZNF320 ZBTB17 ZNF560 KLF10 ZNF473 ZNF423 ZNF587 ZNF846 ZNF621 ZNF772 REST ZNF90 ZNF763 ZNF626 ZNF417 ZFPM2 PRDM2 | 1.44e-14 | 805 | 65 | 22 | IPR007087 |
| Domain | ZnF_C2H2 | ZNF419 ZNF93 ZNF131 KLF12 ZNF676 ZNF320 ZBTB17 ZNF560 KLF10 ZNF473 ZNF423 ZNF587 ZNF846 ZNF621 ZNF772 REST ZNF90 ZNF763 ZNF626 ZNF417 ZFPM2 PRDM2 | 1.55e-14 | 808 | 65 | 22 | SM00355 |
| Domain | zf-C2H2_6 | ZNF419 ZNF93 ZNF676 ZNF320 ZNF560 ZNF473 ZNF423 ZNF587 ZNF846 ZNF621 ZNF90 ZNF763 ZNF626 ZNF417 PRDM2 | 1.69e-13 | 314 | 65 | 15 | PF13912 |
| Domain | KRAB | ZNF419 ZNF93 ZNF676 ZNF320 ZNF560 ZNF473 ZNF587 ZNF846 ZNF621 ZNF772 ZNF90 ZNF763 ZNF626 ZNF417 | 1.77e-11 | 358 | 65 | 14 | PS50805 |
| Domain | KRAB | ZNF419 ZNF93 ZNF676 ZNF320 ZNF560 ZNF473 ZNF587 ZNF846 ZNF621 ZNF772 ZNF90 ZNF763 ZNF626 ZNF417 | 2.65e-11 | 369 | 65 | 14 | SM00349 |
| Domain | KRAB | ZNF419 ZNF93 ZNF676 ZNF320 ZNF560 ZNF473 ZNF587 ZNF846 ZNF621 ZNF772 ZNF90 ZNF763 ZNF626 ZNF417 | 2.74e-11 | 370 | 65 | 14 | IPR001909 |
| Domain | KRAB | ZNF419 ZNF93 ZNF320 ZNF560 ZNF473 ZNF587 ZNF846 ZNF621 ZNF772 ZNF90 ZNF763 ZNF626 ZNF417 | 2.54e-10 | 358 | 65 | 13 | PF01352 |
| Domain | ZF_DAG_PE_1 | 7.26e-05 | 64 | 65 | 4 | PS00479 | |
| Domain | ZF_DAG_PE_2 | 7.26e-05 | 64 | 65 | 4 | PS50081 | |
| Domain | C1 | 7.71e-05 | 65 | 65 | 4 | SM00109 | |
| Domain | PE/DAG-bd | 8.19e-05 | 66 | 65 | 4 | IPR002219 | |
| Domain | C1_1 | 1.03e-03 | 57 | 65 | 3 | PF00130 | |
| Domain | C2H2_Znf_fam | 3.13e-03 | 24 | 65 | 2 | IPR027775 | |
| Domain | BTB | 1.07e-02 | 131 | 65 | 3 | PF00651 | |
| Pubmed | 7.56e-08 | 181 | 69 | 7 | 37372979 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 25261598 | ||
| Pubmed | Novel G protein-coupled receptors: a gene family of putative human olfactory receptor sequences. | 3.88e-06 | 2 | 69 | 2 | 1315913 | |
| Pubmed | Sequence, structure, and evolution of a complete human olfactory receptor gene cluster. | 4.11e-06 | 16 | 69 | 3 | 10673334 | |
| Pubmed | ZNF419 ZNF93 ZNF131 KLF12 ZBTB17 KLF10 ZNF473 ZNF423 REST ZNF626 | 4.28e-06 | 808 | 69 | 10 | 20412781 | |
| Pubmed | Characterization and mapping of human genes encoding zinc finger proteins. | 1.12e-05 | 22 | 69 | 3 | 1946370 | |
| Pubmed | 1.12e-05 | 22 | 69 | 3 | 1505991 | ||
| Pubmed | Cholinergic Neurons of the Medial Septum Are Crucial for Sensorimotor Gating. | 2.32e-05 | 4 | 69 | 2 | 31028115 | |
| Pubmed | 2.32e-05 | 4 | 69 | 2 | 18774262 | ||
| Pubmed | mGluR5 regulates REST/NRSF signaling through N-cadherin/β-catenin complex in Huntington's disease. | 3.86e-05 | 5 | 69 | 2 | 32859226 | |
| Pubmed | 5.79e-05 | 6 | 69 | 2 | 32015321 | ||
| Pubmed | 5.79e-05 | 6 | 69 | 2 | 23134681 | ||
| Pubmed | 8.09e-05 | 7 | 69 | 2 | 15381704 | ||
| Pubmed | 1.08e-04 | 8 | 69 | 2 | 22298430 | ||
| Pubmed | 1.08e-04 | 8 | 69 | 2 | 2023909 | ||
| Pubmed | Protein-protein interaction of zinc finger LIM domains with protein kinase C. | 1.08e-04 | 8 | 69 | 2 | 8940095 | |
| Pubmed | 1.08e-04 | 8 | 69 | 2 | 15894802 | ||
| Pubmed | Mouse-human orthology relationships in an olfactory receptor gene cluster. | 1.08e-04 | 8 | 69 | 2 | 11170746 | |
| Pubmed | 2.11e-04 | 11 | 69 | 2 | 8004088 | ||
| Pubmed | HIV-1 Tat and AIDS-associated cancer: targeting the cellular anti-cancer barrier? | 2.53e-04 | 12 | 69 | 2 | 18577246 | |
| Pubmed | 2.68e-04 | 156 | 69 | 4 | 32850835 | ||
| Pubmed | 4.01e-04 | 15 | 69 | 2 | 31812516 | ||
| Pubmed | 4.56e-04 | 75 | 69 | 3 | 29459360 | ||
| Pubmed | 4.57e-04 | 16 | 69 | 2 | 8467795 | ||
| Pubmed | Role of topoisomerase IIbeta in the expression of developmentally regulated genes. | 4.57e-04 | 16 | 69 | 2 | 16923961 | |
| Pubmed | 5.18e-04 | 17 | 69 | 2 | 23082233 | ||
| Pubmed | 5.18e-04 | 17 | 69 | 2 | 7557990 | ||
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | 6.87e-04 | 536 | 69 | 6 | 15840001 | |
| Pubmed | 7.00e-04 | 538 | 69 | 6 | 10512203 | ||
| Pubmed | 7.95e-04 | 21 | 69 | 2 | 25113559 | ||
| Pubmed | 9.55e-04 | 23 | 69 | 2 | 31748650 | ||
| Pubmed | DEFOG: a practical scheme for deciphering families of genes. | 9.60e-04 | 219 | 69 | 4 | 12213199 | |
| Pubmed | 1.13e-03 | 25 | 69 | 2 | 26718003 | ||
| Pubmed | 1.13e-03 | 25 | 69 | 2 | 8858346 | ||
| Pubmed | Dystroglycan Maintains Inner Limiting Membrane Integrity to Coordinate Retinal Development. | 1.13e-03 | 25 | 69 | 2 | 28760865 | |
| Pubmed | Mammalian SP/KLF transcription factors: bring in the family. | 1.13e-03 | 25 | 69 | 2 | 15820306 | |
| Pubmed | 1.15e-03 | 103 | 69 | 3 | 10819331 | ||
| Pubmed | 1.31e-03 | 608 | 69 | 6 | 16713569 | ||
| Pubmed | TERRA transcripts are bound by a complex array of RNA-binding proteins. | 1.42e-03 | 28 | 69 | 2 | 20975687 | |
| Pubmed | Prox2 and Runx3 vagal sensory neurons regulate esophageal motility. | 1.52e-03 | 29 | 69 | 2 | 37192624 | |
| Pubmed | 1.52e-03 | 29 | 69 | 2 | 14563677 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 1.66e-03 | 430 | 69 | 5 | 35044719 | |
| Pubmed | Single-cell transcriptomic analysis reveals diversity within mammalian spinal motor neurons. | 1.85e-03 | 32 | 69 | 2 | 36596814 | |
| Cytoband | 19p12 | 5.20e-09 | 90 | 69 | 6 | 19p12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p12 | 3.25e-08 | 122 | 69 | 6 | chr19p12 | |
| Cytoband | 19q13.43 | 9.47e-06 | 87 | 69 | 4 | 19q13.43 | |
| Cytoband | 17p13.3 | 3.25e-04 | 88 | 69 | 3 | 17p13.3 | |
| Cytoband | 19p13.2 | 4.04e-04 | 229 | 69 | 4 | 19p13.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17p13 | 1.86e-03 | 346 | 69 | 4 | chr17p13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr8q22 | 2.11e-03 | 168 | 69 | 3 | chr8q22 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF419 ZNF93 ZNF131 KLF12 ZNF676 ZNF320 ZBTB17 ZNF560 KLF10 ZNF473 ZNF423 ZNF587 ZNF846 ZNF621 ZNF772 ZNF90 ZNF763 ZNF626 ZNF417 ZFPM2 | 1.13e-15 | 718 | 50 | 20 | 28 |
| GeneFamily | Olfactory receptors, family 1 | 1.83e-04 | 40 | 50 | 3 | 147 | |
| GeneFamily | Zinc fingers C2H2-type|Kruppel like factors | 1.11e-03 | 18 | 50 | 2 | 624 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.02e-05 | 188 | 68 | 5 | 293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11 | |
| ToppCell | Lung_Parenchyma-Control-Myeloid-Mast_cell|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.31e-05 | 198 | 68 | 5 | 0af55f2b859e4626e23e2733bf9ae2ace4547079 | |
| ToppCell | Lung_Parenchyma-Control-Myeloid-Mast_cell-Mast_cells-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.31e-05 | 198 | 68 | 5 | f75800b4f3cf0d493226db8db7c949caade0ff90 | |
| ToppCell | Parenchyma_Control_(B.)-Immune-TX-Mast_cells|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.31e-05 | 198 | 68 | 5 | 45089e0adf2c00f4b0bccd701f4daebf25858006 | |
| ToppCell | Lung_Parenchyma-Control-Myeloid-Mast_cell-Mast_cells|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.31e-05 | 198 | 68 | 5 | 4163220f4ccb825a8399298cfac8411eb2acc9a2 | |
| ToppCell | 367C-Lymphocytic-ILC-ILC-2|ILC / Donor, Lineage, Cell class and subclass (all cells) | 8.19e-05 | 55 | 68 | 3 | 7916216b3a24f9c6b966aa5392fc2bc43b3d2c4c | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.00e-04 | 158 | 68 | 4 | e7db0ee4740e3c7a4d97d7cd7462e2c2ab458a4b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.00e-04 | 158 | 68 | 4 | d39e020c3e77eb9d3de600a171d22f94357061d4 | |
| ToppCell | Control-B_cells-Activated_B_cells|Control / group, cell type (main and fine annotations) | 1.27e-04 | 168 | 68 | 4 | a7159a35fe37f8c241cf8d391debe271e0698105 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-innate_lymphocytic-innate_lymphoid_cell|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.33e-04 | 170 | 68 | 4 | 6c65ddb496030bb479ef346cc37a9d4dfa6b824f | |
| ToppCell | COVID-19-kidney-PEC|kidney / Disease (COVID-19 only), tissue and cell type | 1.39e-04 | 172 | 68 | 4 | 36a96714a0eb6ac438648135336c9791881ddadb | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Dendritic-migDC|lymph-node_spleen / Manually curated celltypes from each tissue | 1.39e-04 | 172 | 68 | 4 | 1b24bed3cd8e3fa463c5e7cefdf9e99e639e2f84 | |
| ToppCell | E12.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.39e-04 | 172 | 68 | 4 | 3b9be685fcd1634498a603b692f5ac6ddd0de176 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.48e-04 | 175 | 68 | 4 | 06eace2e681980456299167b48bd49bcfea5e940 | |
| ToppCell | Endothelial-B-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 1.52e-04 | 176 | 68 | 4 | b288116a4588a1f9db9d49af92cea118937c9201 | |
| ToppCell | nucseq-Immune-Lymphocytic_B-Lymphocytic_B-B|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.69e-04 | 181 | 68 | 4 | 8d8cc4dae2c8bd5f4b1c159f2a52edc4c9449c86 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.72e-04 | 182 | 68 | 4 | 7ded554a4b441e6496db673ba206c0d76ccad7d9 | |
| ToppCell | nucseq-Immune-Lymphocytic_B-Lymphocytic_B|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.80e-04 | 184 | 68 | 4 | 942b58ae7172bb5f97e55b032db9329d161854af | |
| ToppCell | nucseq-Immune-Lymphocytic_B|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.80e-04 | 184 | 68 | 4 | 911658e7bb499c1bbc8419eec8ff88729bc39a75 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.80e-04 | 184 | 68 | 4 | 5daff849625f2f41d56615569c0ed59cd733b34c | |
| ToppCell | Adult-Epithelial-ciliated_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.83e-04 | 185 | 68 | 4 | 30f4980dee6cd5959655f8d74049f3bfb5312611 | |
| ToppCell | PBMC-Mild-cDC_8|Mild / Compartment, Disease Groups and Clusters | 1.83e-04 | 185 | 68 | 4 | 891b39c20fe9858fbba90d9ef7a253f1a0870211 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.83e-04 | 185 | 68 | 4 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.87e-04 | 186 | 68 | 4 | 6add08d4ca019ff2864acdd5ec2c66a59a574591 | |
| ToppCell | Control-T_cells|Control / group, cell type (main and fine annotations) | 1.91e-04 | 187 | 68 | 4 | f4e8e0eba58da89b56587667555a5d4754e108c7 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T2|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.91e-04 | 187 | 68 | 4 | f3e37c18ac6471c7992609bbddfa4975571c815c | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 1.95e-04 | 188 | 68 | 4 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.95e-04 | 188 | 68 | 4 | 2b6dfc88be9ded7b88da9fe78a9cd9f9b3af8af3 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 1.99e-04 | 189 | 68 | 4 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.99e-04 | 189 | 68 | 4 | 68a3cf7763d6f9b95d6d6524eff7a16042703f1d | |
| ToppCell | ASK428-Epithelial-Transformed_epithelium|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.99e-04 | 189 | 68 | 4 | 87189275234b5d59484c58acbb14a09903f2b578 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.07e-04 | 191 | 68 | 4 | 107113b930d9ad171f1b2aa20df4567c94fae7d8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.07e-04 | 191 | 68 | 4 | bc353a79a1d11ca52bba5e3874a80d432e1a7715 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.16e-04 | 193 | 68 | 4 | 469a7f1c2ff7137cc5a064464456911f67f92e70 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.16e-04 | 193 | 68 | 4 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | COVID-19-kidney-T-cells-1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.16e-04 | 193 | 68 | 4 | 5b84fa640cf30dea55fde53b810f850ff946d253 | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 2.16e-04 | 193 | 68 | 4 | ad58f5080e0ba65c845056ea6b79037b636e9c64 | |
| ToppCell | Immune-T_lymphocyte|World / Lineage, Cell type, age group and donor | 2.20e-04 | 194 | 68 | 4 | f47fa18c87b35a3960557f8169ff7830dd6ecb80 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-NK-NK-F_2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.20e-04 | 194 | 68 | 4 | 5031f324628ff12a33e84cc52157be4786e0961d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.24e-04 | 195 | 68 | 4 | dd281a249854800f737dc22e0f375f66dfb5cf5f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.24e-04 | 195 | 68 | 4 | edd4cd8402af81737b2074f9dce71cc6ab09be7e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.24e-04 | 195 | 68 | 4 | 49c99553629cdd83ee56a2e508d5bc8d34b8507b | |
| ToppCell | metastatic_Lymph_Node-T/NK_cells-CD4+_Th|T/NK_cells / Location, Cell class and cell subclass | 2.24e-04 | 195 | 68 | 4 | 944158240cfc3b2cf72a6601b4e02d8d31a903b9 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.24e-04 | 195 | 68 | 4 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.29e-04 | 196 | 68 | 4 | 802f61e78a9a1030a86c4a980c398a73cd4d1574 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.29e-04 | 196 | 68 | 4 | 2b36b9a40fe415917afccff99ad9c3474e087d0d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.29e-04 | 196 | 68 | 4 | fa445f4240c521cf04eb2e2f79a5c55fda31209a | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.33e-04 | 197 | 68 | 4 | 6d027119a5f7ca2aac1b10837e43f9a2bb54db85 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.33e-04 | 197 | 68 | 4 | 80e153790cef37b743e22a7370ff5b3a6abf147d | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.33e-04 | 197 | 68 | 4 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.38e-04 | 198 | 68 | 4 | 5f465cf5c7493e32d9afe9e9d05757d0a95acc33 | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B-B_lineage|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.38e-04 | 198 | 68 | 4 | 77ce3fe1ab161c0faf8987e73a64ab61294b9255 | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-basal_cell_of_epidermis|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-04 | 198 | 68 | 4 | 22559b161e67b49fe8028bfaf861e069063599f5 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.42e-04 | 199 | 68 | 4 | 542ec45c931b40738df1f3777b00c83be33a514a | |
| ToppCell | mLN-ILC|mLN / Region, Cell class and subclass | 2.42e-04 | 199 | 68 | 4 | d6c299312c747fb1b7c53644c53efc03a5fffe85 | |
| ToppCell | mLN-(3)_ILC|mLN / shred on region, Cell_type, and subtype | 2.42e-04 | 199 | 68 | 4 | 00e0e2a766dd9c4d0a65f53d88fa50df4b6a3d60 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.42e-04 | 199 | 68 | 4 | e9820d5fb4e8b46973c4c50ac5db8fb4a1bf603b | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.42e-04 | 199 | 68 | 4 | 2498237b9e895ca4826a3378d9d40989968df72b | |
| ToppCell | mLN-(3)_ILC-(30)_ILC|mLN / shred on region, Cell_type, and subtype | 2.42e-04 | 199 | 68 | 4 | 33ac6d77099076df01299be429f4ba96f2f34cc1 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.42e-04 | 199 | 68 | 4 | 38cfd367ee8c074c11ba54edeb7a001e375e2687 | |
| ToppCell | mLN-ILC-ILC|mLN / Region, Cell class and subclass | 2.42e-04 | 199 | 68 | 4 | ab09a06cdea2597e9fe4b4b304655e9de4d433f6 | |
| ToppCell | Tracheal-NucSeq-Stromal-Chondrocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.47e-04 | 200 | 68 | 4 | b5a54b9baf79aea01f76a161f0a39bbe87eb4945 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.47e-04 | 200 | 68 | 4 | af6a551f83808c1c839df7ba7b1702ca28ea6e1b | |
| ToppCell | Tracheal-NucSeq-Stromal-Chondrocytic-Chondrocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.47e-04 | 200 | 68 | 4 | f5bd0b30e478dac09f68c46b0781f5f2e7e3c693 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.47e-04 | 200 | 68 | 4 | 87827041663013f5e7273168dc8709d69840e7ce | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.47e-04 | 200 | 68 | 4 | 73ac1cf40ddd764be1100cbfaaa29563665457d8 | |
| Computational | B lymphoma expression clusters. | 4.18e-04 | 149 | 26 | 4 | MODULE_361 | |
| Computational | Genes in the cancer module 301. | 5.22e-04 | 158 | 26 | 4 | MODULE_301 | |
| Computational | Genes in the cancer module 238. | 6.01e-04 | 164 | 26 | 4 | MODULE_238 | |
| Drug | 3-Acetylcoumarin [3949-36-8]; Down 200; 21.2uM; MCF7; HT_HG-U133A | 1.34e-07 | 198 | 68 | 8 | 5259_DN | |
| Drug | Betazole hydrochloride; Up 200; 27uM; MCF7; HT_HG-U133A | 1.45e-07 | 200 | 68 | 8 | 5445_UP | |
| Drug | Trichlorfon [52-68-6]; Down 200; 15.6uM; MCF7; HT_HG-U133A | 1.77e-06 | 193 | 68 | 7 | 5989_DN | |
| Drug | NS-105 | 3.01e-06 | 10 | 68 | 3 | CID000198695 | |
| Drug | Dipyrone [5907-38-0]; Down 200; 12uM; PC3; HT_HG-U133A | 2.09e-05 | 188 | 68 | 6 | 4310_DN | |
| Drug | Guanfacine hydrochloride [29110-48-3]; Down 200; 14.2uM; MCF7; HT_HG-U133A | 2.29e-05 | 191 | 68 | 6 | 2634_DN | |
| Drug | Meclozine dihydrochloride [1104-22-9]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 2.50e-05 | 194 | 68 | 6 | 3285_UP | |
| Drug | S)-2-amino-2-methyl-4-phosphonobutanoic acid | 2.63e-05 | 3 | 68 | 2 | CID001795542 | |
| Drug | Meclofenoxate hydrochloride [3685-84-5]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 2.80e-05 | 198 | 68 | 6 | 4729_DN | |
| Drug | Proxyphylline [603-00-9]; Up 200; 16.8uM; PC3; HT_HG-U133A | 2.88e-05 | 199 | 68 | 6 | 7290_UP | |
| Drug | Panthenol (D) [81-13-0]; Up 200; 19.4uM; MCF7; HT_HG-U133A | 2.97e-05 | 200 | 68 | 6 | 7455_UP | |
| Disease | level of triacylglycerol (56:6) in blood serum | 5.62e-04 | 16 | 65 | 2 | OBA_2020007 | |
| Disease | age-related macular degeneration | 1.01e-03 | 89 | 65 | 3 | EFO_0001365 | |
| Disease | Autosomal dominant nonsyndromic hearing loss | 1.87e-03 | 29 | 65 | 2 | cv:C5779548 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KKAGAHSVYACELSK | 196 | Q6P2P2 | |
| KTYSEFCSRHSKALK | 336 | Q92974 | |
| CKDKKSYTPLHAAAS | 201 | O15084 | |
| KVKTLVFCSGKHFYS | 801 | Q96HY7 | |
| AKKASYSHNFSKKSS | 566 | Q7Z3E1 | |
| CDYKTADRSNFKKHV | 366 | Q13127 | |
| KYNKTCNSSLTLKTH | 376 | P41594 | |
| KKTCTKIDYCASSNH | 356 | O00339 | |
| SKKVSYSHIQSKCGS | 996 | P27816 | |
| VAFSTSSYSCGRKKK | 26 | Q9BQP7 | |
| LSNFITHKKFYCSSH | 1131 | Q8WW38 | |
| KHKFKIHTYSSPTFC | 101 | P05771 | |
| GKVIKFATSHVYSCS | 661 | Q6ZWE6 | |
| KKSSSTYTFCKSVGL | 911 | Q9UPP2 | |
| YSKKDRPLCKSHAFS | 441 | Q9NR12 | |
| TKGKYKAFSTCGSHL | 231 | Q8NG98 | |
| IKATFAYISNCHKTK | 1386 | Q13315 | |
| DTHSLKTLFTKCKNF | 176 | Q6TFL4 | |
| FAKCFHTSFSKCTKL | 1336 | Q5T9S5 | |
| AKHKQSSFTKSCYPR | 21 | Q9NPH9 | |
| ACYAKTSSLTKAKEV | 386 | Q5TEA3 | |
| GFEYFKSASCHTSKK | 1181 | Q9P267 | |
| DHACKSSARKQAKSY | 376 | Q6ZW76 | |
| CGKTYFKSSHLKAHT | 376 | Q13118 | |
| FEGCNKVYTKSSHLK | 321 | Q9Y4X4 | |
| AKYKKLLFSLCFFHS | 3976 | Q9P225 | |
| HVYLAFNSICKASTK | 511 | Q6ZTR5 | |
| SSKTNHHSCLYSAVK | 711 | Q8NG08 | |
| AVSFHKEKSVYLSSK | 676 | Q13029 | |
| VSKKYKAFSTCASHL | 231 | P34982 | |
| ASKKYKTFSTCASHL | 231 | P47884 | |
| ASKKYKTFSTCASHL | 231 | P58170 | |
| SDYNLSSHILKKCSK | 221 | A8MW99 | |
| FHAKYGNLEKCASKS | 781 | Q6NUP7 | |
| TKFTVETACKEYKHS | 196 | Q02880 | |
| CFKVKHDALKTYASL | 96 | Q8IUX1 | |
| TSKVHNKTVYCEFLK | 1431 | B5MCY1 | |
| ESFKSTKHNICFTKS | 646 | Q14940 | |
| GFYFDKKSCKSKHQT | 1501 | Q13023 | |
| NDITSYKFKSLKHCV | 336 | Q53FZ2 | |
| FHSCKETSSSKFAKA | 696 | P28329 | |
| FSKCHSKVNPTFFYK | 1311 | O75443 | |
| STFKHYSCISELNSK | 211 | Q96JG6 | |
| CGKAFKYSSALNTHK | 206 | P35789 | |
| CGKAFKSSSTVSYHK | 566 | Q8N7Q3 | |
| KECGKAFIHSSYLTK | 341 | Q147U1 | |
| GKVFSTKAYLACHQK | 391 | A2RRD8 | |
| SYTFKSTVKKIAKCS | 56 | Q8NB66 | |
| SYHETSKMKVLKFAC | 611 | Q12816 | |
| CYSSVHKKDLKSVVA | 266 | Q8N5U6 | |
| NYSCGKRTKAFSTKH | 211 | Q96SQ5 | |
| QCDKYVKVFHKFSSS | 146 | P0DPD5 | |
| NYSCGKRTKAFSTKH | 211 | Q8TAU3 | |
| TCEKAFKYRSNFTKH | 421 | A6NDX5 | |
| GKTDAFICKYKKSHS | 486 | Q9BTF0 | |
| LSRSAFKFKKSSKYC | 291 | Q9P273 | |
| CGKAFKYSSTLTTHK | 346 | Q68DY1 | |
| KAFKSSYDCIVHEKN | 186 | Q6ZSS3 | |
| KAHKAVLAACSEYFK | 36 | Q13105 | |
| CDKAFKYSSALSTHK | 486 | Q03938 | |
| EAFKYSCSLTAHKII | 376 | Q6ZN08 | |
| KAHKAVLAACSKFFY | 46 | P52739 | |
| TTHSKKYNCKFCSKA | 801 | Q2M1K9 | |
| SAETNKKTVHAKYCS | 436 | Q502W6 | |
| KQCVKSFSYSATHRI | 231 | Q0D2J5 | |
| SECGKFYSHKSNLIK | 346 | Q96HQ0 | |
| KCSECGKAYSHKSTL | 351 | Q68DY9 | |
| KAFTKCSYLTKHLRT | 551 | Q96MR9 | |
| KCEKTFSCSKYLTQH | 566 | Q8WTR7 |